.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Colorcon
Accenture
Chubb
Boehringer Ingelheim
UBS
Johnson and Johnson
AstraZeneca
McKinsey
Novartis

Generated: July 22, 2017

DrugPatentWatch Database Preview

PROMETH W/ DEXTROMETHORPHAN Drug Profile

« Back to Dashboard

What is the patent landscape for Prometh W/ Dextromethorphan, and what generic Prometh W/ Dextromethorphan alternatives are available?

Prometh W/ Dextromethorphan is a drug marketed by G And W Labs Inc and is included in one NDA.

The generic ingredient in PROMETH W/ DEXTROMETHORPHAN is dextromethorphan hydrobromide; promethazine hydrochloride. There are twenty-two drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the dextromethorphan hydrobromide; promethazine hydrochloride profile page.

Summary for Tradename: PROMETH W/ DEXTROMETHORPHAN

Patents:0
Applicants:1
NDAs:1
Clinical Trials: see list120
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROMETH W/ DEXTROMETHORPHAN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc
PROMETH W/ DEXTROMETHORPHAN
dextromethorphan hydrobromide; promethazine hydrochloride
SYRUP;ORAL088762-001Oct 31, 1984AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Accenture
Express Scripts
Cantor Fitzgerald
Cipla
Johnson and Johnson
Teva
Fish and Richardson
Daiichi Sankyo
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot